Dr. Wang is a staff scientist at Wisconsin Center for NanoBioSystems (WisCNano) where he manages the core facility and its website. Through WisCNano, he is involved in several collaborative research studies across the campus. Jason is also an assistant scientist in the Hong Research Group with a focus on the development of immunotherapies for cancer and other diseases using peptide dendrimer conjugates (PDCs) and polymeric micelles.

Dr. Wang graduated from Tianjin University of Science and Technology (Tianjin, China) with a BS in bioengineering and an MS in microbial and biochemical pharmacy via a joint study on structural biology at Nankai University (Tianjin, China) before earning a PhD in chemistry from Purdue University with a focus on the development of gold nanoparticle formulations for biomedical applications.

His paper on the topic of siRNA delivery using gold nanorods (Bioconjugate Chem. 30 (2), 443-453) was selected in the special issue of BC–Delivery of Proteins and Nucleic Acids: Achievements and Challenges. Later Jason went on to a postdoc position in Dr. Emily Day’s group at the University of Delaware with a focus of studying triple negative breast cancer (TNBC) therapy through Wnt pathway manipulation and near-infrared (NIR) photothermal therapy.